Human immune recognition-based multicomponent subunit vaccines against tuberculosis

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 902-910

  Sable, S B ^a   Verma, I ^a   Behera, D ^a   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Human immunity; Multicomponent subunit vaccine; Tuberculosis

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; GAMMA INTERFERON; MULTICOMPONENT SUBUNIT VACCINE 1; MULTICOMPONENT SUBUNIT VACCINE 2; POLYPEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TH1 CELL;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, ACTIVE; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, SUBUNIT;

EID: 18744388052     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00105404     Document Type: Article

References (31)

1. Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992; 60: 4781-4792.
2. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62: 2536-2544.
3. Horwitz MA, Lee BW, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995; 92: 1530-1534.
4. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 2000; 68: 791-795.
5. Coler RN, Campos-Neto A, Ovendale P, et al. Vaccination with T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 2001; 166: 6227-6235.
6. 37Ra. Vaccine 1997; 15: 689-699.
7. 37Rv and its protective efficacy against experimental tuberculosis. J Med Microbiol 1999; 48: 757-763.
8. Olsen AW, Van Pinxten LAH, Okkels LM, Rasmussen PB, Andersen P. Protection in mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect Immun 2001; 69: 2773-2778.
9. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T cell responses to secreted antigen fraction of Mycobacterium tuberculosis. Infect Immun 1995; 3: 1491-1497.
10. Bhaskar S, Khanna SP, Mukherjee R. Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP6 from culture filtrate of M. tuberculosis. Vaccine 2000; 18: 2856-2866.
11. Demissie A, Ravn P, Olobo J, et al. T cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun 1999; 67: 5967-5971.
12. A tuberculosis subunit vaccine based on a fusion protein of Ag85B and ESAT-6; broad human immune recognition and prolonged survival of TB infected mice and guinea pigs. In: Arend SM. Cellular immune responses to mycobacteria: towards specific immunodiagnosis and protection. PhD thesis. Dept of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands, 2002; pp. 77-97.
13. National Tuberculosis and Respiratory Disease Association. Diagnostic Standards and Classification of Tuberculosis. New York, NY, National Tuberculosis and Respiratory Disease Association, 1969.
14. Subrahmanyam D. Studies on the polyglycerolphosphatide of Mycobacterium tuberculosis. Can J Biochem Physiol 1964; 42: 1195-1201.
15. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991; 59: 372-382.
16. Parish CR, Mullbacher A. Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods 1983; 58: 225-237.
17. Camus JC, Pryor MJ, Medigue C, Cole ST. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 2002; 148: 2967-2973.
18. Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000; 30: 1724-1732.
19. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183: 469-477.
20. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon resposnses to ESAT-6 than do community controls in the Gambia. Infect Immun 2001; 69: 6554-6557.
21. Skjøt RL, Oettinger T, Rosenkrands I, et al. Comparative evaluation of low molecular mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T cell antigens. Infect Immun 2000; 68: 214-220.
22. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16-22.
23. Lewis KN, Liao R, Guinn KM, et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis 2003; 187: 117-123.
24. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG. Correlation of ESAT-6 specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002; 70: 3026-3032.
25. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40: 704-706.
26. Renshaw PS, Panagiotidou P, Whelan A, et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10 and the ESAT-6-CFP-10 complex: implications for pathogenesis and virulence. J Biol Chem 2002; 277: 21598-21603.
27. Hsu T, Hingley-Wilson SM, Chen B, et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 2003; 100: 12420-12425.
28. Torres M, Herrera T, Villareal H, Rich EA, Sada E. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30 kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998; 66: 176-180.
29. Harboe M, Wiker HG, Ulvund G, et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 1998; 66: 717-723.
30. Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 2003; 71: 4225-4228.
31. Williams A, Reljic R, Naylor I, et al. Passive protection with immunoglobulin A antibodies against tuberculosis early infection of the lungs. Immunology 2004; 111: 328-333.